Key Laboratory of Chemical Biology & Traditional Chinese Medicine Research, Ministry of Education, Hunan Normal University, Changsha 410081, China.
J Chromatogr A. 2010 Jan 15;1217(3):243-9. doi: 10.1016/j.chroma.2009.11.037. Epub 2009 Nov 18.
Novel sample preparation approaches for HPLC bioanalysis based on the phenomenon that acetonitrile can be separated from water by adding salts or cooling at subzero temperatures have been reported. These two methods are superior to conventional liquid-liquid extraction since the separated acetonitrile phase can be directly injected to the RP-LC system. However, the salting-out method suffers from a potential problem that the remained salt in the acetonitrile phase may harm the MS detector, while the subzero-temperature method is troublesome to operate. Here, we have reported a similar phase separation phenomenon that the acetonitrile aqueous mixture can be separated by adding a hydrophobic solvent; and capitalising on this phase transition phenomenon, we have proposed an alternative approach, named solvent induced phase transition extraction (SIPTE), to extract drug from plasma for HPLC-MS analysis. The proposed SIPTE method is much simpler and avoids contaminating the MS detector. Three structurally diverse drugs were selected as test compounds to design the SIPTE method and to validate the efficiency of this method. The four goals of plasma sample pretreatment for HPLC-MS analysis, i.e. removal of proteins, removal of other low-molecular interferences, preconcentration of the analytes of interest, and matching the sample solvent with the HPLC-MS system, can be rapidly performed in a very simple step by using the SIPTE method.
已报道了基于乙腈可通过加盐或在零下温度冷却而与水分离的现象的新型 HPLC 生物分析样品制备方法。与传统的液液萃取相比,这两种方法更具优势,因为分离出的乙腈相可直接注入反相高效液相色谱系统。然而,盐析法存在一个潜在问题,即乙腈相中残留的盐可能会损坏 MS 检测器,而低温法操作麻烦。在这里,我们报道了一种类似的相分离现象,即乙腈水混合物可通过添加疏溶剂来分离;并利用这种相变现象,我们提出了一种替代方法,命名为溶剂诱导相转变萃取(SIPTE),用于从血浆中提取药物进行 HPLC-MS 分析。所提出的 SIPTE 方法更为简单,并且避免了对 MS 检测器的污染。选择三种结构不同的药物作为测试化合物来设计 SIPTE 方法,并验证该方法的效率。使用 SIPTE 方法可以在非常简单的一步中快速实现 HPLC-MS 分析中血浆样品预处理的四个目标,即去除蛋白质、去除其他低分子干扰物、浓缩感兴趣的分析物以及使样品溶剂与 HPLC-MS 系统匹配。